Literature DB >> 2100197

The in vitro biological effect of nerve growth factor is inhibited by synthetic peptides.

F M Longo1, T K Vu, W C Mobley.   

Abstract

Nerve growth factor (NGF)1 is a neurotrophic polypeptide that acts via specific receptors to promote the survival and growth of neurons. To delineate the NGF domain(s) responsible for eliciting biological activity, we synthesized small peptides corresponding to three regions in NGF that are hydrophilic and highly conserved. Several peptides from mouse NGF region 26-40 inhibited the neurite-promoting effect of NGF on sensory neurons in vitro. Inhibition was sequence-specific and could be overcome by increasing the concentration of NGF. Moreover, peptide actions were specific for NGF-mediated events in that they failed to block the neurotrophic activity of ciliary neuronotrophic factor (CNTF) or phorbol 12-myristate 13-acetate (PMA). In spite of the inhibition of NGF activity, peptides did not affect the binding of radiolabeled NGF. These studies define one region of NGF that may be required for neurotrophic activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2100197      PMCID: PMC361440          DOI: 10.1091/mbc.1.2.189

Source DB:  PubMed          Journal:  Cell Regul        ISSN: 1044-2030


  25 in total

1.  Oxidation of tryptophan-21 alters the biological activity and receptor binding characteristics of mouse nerve growth factor.

Authors:  P Cohen; A Sutter; G Landreth; A Zimmermann; E M Shooter
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

2.  Topography of mouse 2.5S nerve growth factor. Reactivity of tyrosine and tryptophan.

Authors:  W A Frazier; R A Hogue-Angeletti; R Sherman; R A Bradshaw
Journal:  Biochemistry       Date:  1973-08-14       Impact factor: 3.162

3.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

Review 4.  Polypeptide growth factors.

Authors:  R James; R A Bradshaw
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

5.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule.

Authors:  M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1984 May 3-9       Impact factor: 49.962

6.  Nerve growth factor receptors. Characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells.

Authors:  A Sutter; R J Riopelle; R M Harris-Warrick; E M Shooter
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

7.  Spinal cord neuronotrophic factors (SCNTFs): I. Bioassay of schwannoma and other conditioned media.

Authors:  F M Longo; M Manthorpe; S Varon
Journal:  Brain Res       Date:  1982-02       Impact factor: 3.252

8.  Tumor-promoting phorbol diester mimics two distinct neuronotrophic factors.

Authors:  H P Montz; G E Davis; S D Skaper; M Manthorpe; S Varon
Journal:  Brain Res       Date:  1985-11       Impact factor: 3.252

9.  Structure and expression of the chicken beta nerve growth factor gene.

Authors:  T Ebendal; D Larhammar; H Persson
Journal:  EMBO J       Date:  1986-07       Impact factor: 11.598

10.  Biologically active synthetic peptides as probes of embryonic development: a competitive peptide inhibitor of fibronectin function inhibits gastrulation in amphibian embryos and neural crest cell migration in avian embryos.

Authors:  J C Boucaut; T Darribère; T J Poole; H Aoyama; K M Yamada; J P Thiery
Journal:  J Cell Biol       Date:  1984-11       Impact factor: 10.539

View more
  8 in total

1.  Nerve growth factor: structure/function relationships.

Authors:  R A Bradshaw; J Murray-Rust; C F Ibáñez; N Q McDonald; R Lapatto; T L Blundell
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

2.  Alzheimer's therapeutics: neurotrophin small molecule mimetics.

Authors:  Stephen M Massa; Youmei Xie; Frank M Longo
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

3.  A nerve growth factor peptide retards seizure development and inhibits neuronal sprouting in a rat model of epilepsy.

Authors:  K Rashid; C E Van der Zee; G M Ross; C A Chapman; J Stanisz; R J Riopelle; R J Racine; M Fahnestock
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

Review 4.  Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease.

Authors:  Frank M Longo; Stephen M Massa
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

Review 5.  Peptides Derived from Growth Factors to Treat Alzheimer's Disease.

Authors:  Suzanne Gascon; Jessica Jann; Chloé Langlois-Blais; Mélanie Plourde; Christine Lavoie; Nathalie Faucheux
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

6.  Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.

Authors:  T F Lane; E H Sage
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

7.  Rescuing cholinergic neurons from apoptotic degeneration by targeting of serotonin modulator-and apolipoprotein E-conjugated liposomes to the hippocampus.

Authors:  Yung-Chih Kuo; Yin-Jung Lee
Journal:  Int J Nanomedicine       Date:  2016-12-15

8.  Modulation of the p75 neurotrophin receptor suppresses age-related basal forebrain cholinergic neuron degeneration.

Authors:  Youmei Xie; Rick B Meeker; Stephen M Massa; Frank M Longo
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.